Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation and detection method of azo compound

A compound, sodium iodide technology, used in measuring devices, instruments, scientific instruments, etc., can solve problems such as hazards and hidden dangers in drug safety

Pending Publication Date: 2022-07-08
SUNSHINE LAKE PHARM CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Various impurities can be produced in the production process of mirabegron, and the more harmful impurities, especially the genotoxic impurities, may bring harm to the human body, and there are hidden dangers in the safety of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and detection method of azo compound
  • Preparation and detection method of azo compound
  • Preparation and detection method of azo compound

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0092] Preparation of Compound C:

[0093]

[0094] Method 1: Add compound A (12.47g, 1.0eq) and methanol (125mL, 10V) to a 250mL double-neck flask at room temperature, stir and then add NH 4 The solution prepared by Cl (3.1g, 1.5eq) and water (60mL, 5V) and zinc powder (7.58g, 3.0eq) were vacuum-replaced with nitrogen three times and then heated to 65°C, reacted for 5h, and HPLC monitored that compound A was less than 5.0 %, the reaction was completed, cooled to room temperature, filtered, and the filtrate was transferred to a 250 mL single-neck bottle; the temperature was raised to 50 ° C and stirred for 10 h, and then sampled. (50mL) beating for 1h, suction filtration, the wet product is dried under vacuum (-0.09Mpa) at 60°C for 16h to obtain compound C: 6.27g, purity 96.65%, yield 54.3%; Detection: ESI-MS (m / z ):525.3(M+H+); 1 H NMR (400MHz, DMSO-d 6 )δ9.18(brs,4H),8.22(d,J=8.0Hz,2H),8.10(d,J=8.0Hz,2H),7.53(d,J=8.0Hz,2H),7.42(m, 8H), 7.33 (m, 2H), 6.28 (d, 2H), 5.15...

Embodiment 1

[0097]

[0098] Compound C (3 g), 10% Pd / C (0.15 g) and methanol (60 mL) were added to a 100 mL double-necked bottle, and the hydrogen was vacuum-replaced three times. HPLC detected that the content of compound C was less than 1.0%, the reaction was completed, suction filtration, and the filtrate was rotary evaporated to a solid to obtain compound D: 2.7 g, the purity was 96.32%, and the yield was 92.2%; ESI-MS (m / z) : 511.3 (M+H+).

[0099]

[0100] Compound D (1.0g, 1.0eq), sodium iodide (0.59g, 2.0eq) and acetonitrile (30mL) were added to a 50mL double-necked flask, nitrogen was vacuum replaced three times, and t-BuOCl (0.43g, 2.0eq) was added with a syringe ), stirred and reacted at room temperature (25°C) for 6 h and sampled for inspection. HPLC detected that the reaction compound D was less than 1.0%. After the reaction was completed, suction filtration was performed, rinsed with acetonitrile (3 mL) and dried, and the wet product (1.05 g) was added to methanol (10 ...

Embodiment 2

[0102] Instruments and Conditions

[0103]

[0104] Experimental procedure

[0105] Mobile phase Phase A: namely 0.1% formic acid aqueous solution, add 1 mL of formic acid to 1000 mL of ultrapure water, mix well, and sonicate for 10 minutes;

[0106] Mobile phase B phase: acetonitrile;

[0107] Diluent / blank solution: methanol;

[0108] Reference substance stock solution 1: Precisely weigh 37.5 mg of each of compound C and compound E into a 100 mL volumetric flask, add an appropriate amount of methanol to dissolve by ultrasonic, and then dilute to the mark to obtain;

[0109] Reference substance stock solution 2: Precisely pipette 1mL of reference substance stock solution 1 to 50mL volumetric flask, dilute to volume with methanol, and shake well;

[0110] Reference substance stock solution 3: Precisely pipette 1mL of reference substance stock solution 2 to 10mL volumetric flask, dilute to volume with methanol, and shake well;

[0111] Reference substance solution: Preci...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation and detection method of an azo compound, and belongs to the field of medicinal chemistry. The preparation method comprises the following steps: carrying out catalytic hydrogenation reaction and reoxidation reaction on raw materials to prepare a target compound. According to the preparation, analysis and detection method provided by the invention, the target compound can be well obtained, and the content of the target compound can be detected and analyzed, so that the medicine quality is controlled, and the medication safety is improved.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a preparation and detection method of an azo compound. Background technique [0002] Mirabegron, chemical name (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl base] acetic acid aniline, the molecular formula is C 21 H 24 N 4 O 2 S, the structure is as follows: [0003] [0004] Mirabegron is the first beta3-adrenergic agonist drug for the treatment of overactive bladder, which relaxes the detrusor smooth muscle during the storage phase of the bladder filling-voiding cycle, Thereby promoting the increase of bladder capacity, mainly used for the treatment of overactive bladder (OAB) with symptoms of urge incontinence, urgency, and frequent urination. [0005] The production process of mirabegron can produce a variety of impurities, and the more harmful impurities, especially genotoxic impurities, may cause harm to the human body, and there are hid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/06G01N30/14G01N30/12G01N30/02G01N30/72G01N30/34G01N30/86G01N30/88
CPCG01N30/06G01N30/14G01N30/12G01N30/02G01N30/72G01N30/34G01N30/8634G01N30/88G01N2030/067G01N2030/126G01N2030/8872G01N2030/884
Inventor 王仲清许国彬朱文民廖守主刘子健罗会杨小芹
Owner SUNSHINE LAKE PHARM CO LTD